BANGKOK, May 16 (TNA) – Chulalongkorn University’s Faculty of Medicine announced a partnership with the Government Pharmaceutical Organization (GPO) to accelerate the development of antibody immunotherapy drugs for cancer treatment. The goal is to make these drugs available to Thai patients within the next three years at a significantly lower cost. Antibody immunotherapy is a type of cancer…


Go to Source
Author: Pantipa Wacharath